Coupled or uncoupled remodeling, is that the question?

Journal of Musculoskeletal Neuronal Interactions

Volumn 6, Issue 2, 2006, Pages 128-133

  Gasser, Jürg A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bone Remodelling; Coupling; Mechanosensing; Parathyroid Hormone

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BONE MORPHOGENETIC PROTEIN; CALCIUM ION; COLLAGEN TYPE 1; COLLAGENASE; COLONY STIMULATING FACTOR 1; CONNEXIN 43; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR; GELATINASE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; SOMATOMEDIN B; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR;

ARTICLE; BIOMECHANICS; BONE MATRIX; BONE REMODELING; BONE STRESS; BONE TURNOVER; CALCIUM HOMEOSTASIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; EXTRACELLULAR CALCIUM; FEEDBACK SYSTEM; GENETIC TRANSCRIPTION; HORMONE METABOLISM; HUMAN; MECHANOTRANSDUCTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PARACRINE SIGNALING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; VERTEBRA FRACTURE; WRIST FRACTURE;

ANIMALS; BONE AND BONES; BONE REMODELING; HUMANS;

EID: 33746917471     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Frost HM. Dynamics of bone remodeling. In: Little and Brown (eds) BoneBiodynamics. Churchill ISBN: B0000CMFKJ, Boston, MA, USA; 1964:315.
2. Takahashi N, Udagawa N, Takami M, Suda T. Cells in bone, osteoclast generation. In: Bilezikian J (ed) Principles of Bone Biology, 2nd Vol 1, Academic Press, San Diego, CA, USA; 2002:109-126.
3. Boyle WJ, Simmonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423:337-342.
4. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-1508.
5. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine octeoclasts mediated by TGF-β. Nat Med 1996; 7:1132-1136.
6. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR. Chemotactic response of osteoblast-like cells to transforming growth factor β. J Bone Miner Res 1990; 5:825-830.
7. Mundy GR, Rodan SB, Majeska RJ, De Martino S, Trimmier C, Martin TJ, Rodan GA. Unidirectional migration of osteosarcoma cells with osteoblast characteristics in response to products of bone resorption. Calcif Tissue Int 1982; 34:542-546.
8. Mundy GR, Poser JW. Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone. Calcif Tissue Int 1985; 35:164-168.
9. Canalis E, Pash J, Varghese S. Skeletal growth factors. Crit Rev Eukaryot Gene Expr 1993; 3:155-166.
10. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 1989; 81:277-281.
11. Eriksen EF, Axelrod DW, Melsen F. Bone histology and bone histomorphometry. In: Eriksen EF, Axelrod DW, Melsen F (eds) Bone Histomorphometry. Raven Press, New York, NY, USA; 1994:13-20.
12. Jee WSS. The skeletal tissues. In: Weiss L (ed) Histology, Cell and Tissue Biology. Elsevier Biomedical, New York, NY, USA; 1983: 220-255.
13. Burr DB, Martin RB, Schaffler MB, Radin EL. Bone remodeling in response to in vivo fatigue microdamage. J Biomech 1985; 18:189-200.
14. Burr DB, Martin RB. Calculating the probability that microcracks initiate resorption spaces. J Biomech 1993; 18:189-200.
15. Noble B. Bone microdamage and cell apoptosis. Europ Cells Mat 2003; 6:46-56.
16. Burr DB. Targeted and nontargeted remodeling. Bone 2002; 30:2-4.
17. Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic, San Diego, CA, USA; 1996:315-329.
18. Nijweide PJ, Burger EH, Klein-Nulend J. The osteocyte. In: Bilezikian JP Raisz LG, Rodan GA (eds) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, CA, USA; 2002:93-107.
19. van der Plas A, Aarden EM, Feyen JH, de Boer AH, Wiltink A, Alblas MJ, de Leij L, Nijweide PJ. Characteristics and properties of osteocytes in culture. J Bone Miner Res 1994; 9:1697-1704.
20. Bonewald LF. Establishment and characterization of an osteocyte-like cell line, MLO-Y4. J Bone Miner Metab 1999; 17:61-65.
21. Marotti G. The structure of bone tissues and the cellular control of their source. Ital J Anat Embryol 1996; 101:25-79.
22. Civitelli R, Beyer EC, Warlow PM, Robertson AJ, Geist ST, Steinberg TH. Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J Clin Invest 1993; 91:1888-1896.
23. Rubin CT, Lanyon LE. Osteoregulatory nature of mechanical stimuli: function as determinant for adaptive bone remodeling. J Orthop Res 1987; 5:300-310.
24. Jorgensen NR, Teilmann SC, Henriksen Z, Civitelli R, Sorensen OH, Steinberg TH. Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. J Biol Chem 2003; 278:4082-4086.
25. Jiang JX, Cheng B. Mechanical stimulation of gap junctions in bone osteocytes is mediated by prostaglandin E2. Cell Commun Adhes 2001; 8:283-288.
26. Ziros PG, Gil AP, Georgakopoulos T, Habeos I, Kletsas D, Basdra EK, Papavassiliou AG. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J Biol Chem 2002; 277:23934-23941.
27. Turner CH, Robling AG, Duncan RL, Burr DB. Do bone cells behave like a neuronal network? Calcif Tissue Int 2002; 70:435-442.
28. Pavalko FM, Norvell SM, Burr DB, Turner CH, Duncan RL, Bidwell JP. A model for mechanotransduction in bone cells: the load bearing mechanosomes. J Cell Biochem 2003; 88:104-112.
29. Smit TH, Burger EH. Is BMU-coupling a strain regulated phenomenon? A finite element analysis. J Bone Miner Res 2000; 15:301-307.
30. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman, AB Eriksen EF, Ish-Shalom S, Genant HK Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344:1434-1441.
31. Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, Kaufman JM, Clancy AD, Gaich GA. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 2003; 18:9-17.
32. Bradbeer JN, Arlot ME, Meunier PJ, Reeve J. Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol (Oxf) 1992; 37:282-289.
33. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 2003; 18:1932-1941.
34. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 2001; 16:1846-1853.
35. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MH. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 1993; 53:394-399.
36. Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 2003; 18:539-543.
37. Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 2005; 36:948-958.
38. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial. J Bone Miner Res 2000; 15:944-951.
39. Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ, Lindsay R. Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 2003; 88:5212-5220.
40. Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 1993; 91:1138-1148.
41. Hodsman AB, Steer BM. Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces. Bone 1993; 14:523-527.
42. Divieti P, Inomata N, Chapin K, Singh R, Juppner H, Bringhurst FR. Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology 2001; 142:916-925.
43. Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 1995; 136:3632-3638.
44. Leaffer D, Sweeney M, Kellerman LA, Avnur Z, Krstenansky JL, Vickery BH, Caulfield JP. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 1995; 136:3624-3631.
45. Keller HJ, Kneissel M. 2SOST is a target gene for PTH in bone. Bone 2005; 37:148-158.
46. Poole KES, van Bezooijen RL, Loveridge M, Hamersma H, Papapoulos S, Löwik CW, Reeve J. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005; 19:1842-1844.
47. Jones DB, Broeckmann E, Pohl T, Smith EL. Development of a mechanical testing and loading system for trabecular bone studies for long term culture. Europ Cells Mat 2003; 5:48-60.
48. de Boer J, van Blitterswijk C, Lowik C. Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials 2006; 9:1851-1858.